SVACF Insider Trading - SciVac Therapeutics Inc.

Insideraktier

3.290.496 shares

Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Se Højest rangerende aktier

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Se Højest rangerende aktier

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

SciVac Therapeutics Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider	Gennemsnitlig fortjeneste (%)	Aktier Ejet	Dele Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i SVACF / SciVac Therapeutics Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato	Insider	Rapporteret Aktier	Rapporteret Pris	Justeret Aktier	Justeret Pris	Omkostningsgrundlag	dage til Maks	Pris kl Maks	Maks Fortjeneste ($)	Maks. afkast (%)
2023-07-10	GILLIS STEVEN	609.090	1,6500	609.090	1,6500	1.004.998	9	1.5000	-91.363	-9,09
2021-12-03	Beattie Nell	8.200	2,4492	273	73,4760	20.083
2020-04-24	PERCEPTIVE ADVISORS LLC	9.090.909	1,1000	303.030	33,0000	10.000.000
2019-10-04	Diaz-Mitoma Francisco	40.000	0,5000	1.333	15,0000	20.000
2019-10-01	McNulty Christopher	12.000	0,4730	400	14,1900	5.676
2019-10-01	Beattie Nell	10.000	0,4822	333	14,4660	4.822
2019-09-30	Baxter Jeff	150.000	0,5030	5.000	15,0900	75.450
2019-09-30	Diaz-Mitoma Francisco	14.500	0,5000	483	15,0000	7.250
2019-09-23	PERCEPTIVE ADVISORS LLC	20.000.000	0,5000	666.667	15,0000	10.000.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SVACF / SciVac Therapeutics Inc. Insider Trades

Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i SVACF / SciVac Therapeutics Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato	Insider	Rapporteret Aktier	Rapporteret Pris	Justeret Aktier	Justeret Pris	Omkostningsgrundlag	dage til Min	Pris kl Min	Max tab Undgået ($)	Max tab Undgået (%)
2023-04-06	PERCEPTIVE ADVISORS LLC	4.251.563	0,1100	141.719	3,3000	467.672	202	0.4960	-397.379	-84,97
2023-04-05	PERCEPTIVE ADVISORS LLC	1.832.563	0,1300	61.085	3,9000	238.233
2023-04-04	PERCEPTIVE ADVISORS LLC	4.810.623	0,1600	160.354	4,8000	769.700
2021-12-01	PERCEPTIVE ADVISORS LLC	2.707.463	3,3100	90.249	99,3000	8.961.703
2021-06-29	PERCEPTIVE ADVISORS LLC	500.709	3,8000	16.690	114,0000	1.902.694
2021-06-29	PERCEPTIVE ADVISORS LLC	145.548	3,8000	4.852	114,0000	553.082
2021-06-09	PERCEPTIVE ADVISORS LLC	1.102.179	4,0000	36.739	120,0000	4.408.716
2021-06-09	PERCEPTIVE ADVISORS LLC	320.388	4,0000	10.680	120,0000	1.281.552

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil Dato	Handle Dato	Form	Insider	Ticker	Sikkerhedstitel	Kode	Direkte	Dyrke motion Pris	Enhed Pris	Enheder Ændret	Værdi Ændret (1K)	Tilbage Muligheder	Tilbage Aktier
2023-07-18	2023-07-10	4	GILLIS STEVEN See Footnotes	VBIV	Common Shares, no par value per share	P - Purchase	I		1,6500	609.090	1.005		1.043.292
2023-04-06	2023-04-06	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	S - Sale	I		0,1100	-4.251.563	-468		41.440.729
2023-04-06	2023-04-05	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	S - Sale	I		0,1300	-1.832.563	-238		45.691.816
2023-04-06	2023-04-04	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	S - Sale	I		0,1600	-4.810.623	-770		47.524.379
2022-01-31	2022-01-27	4	DeWilde Michel	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,53		75.000		75.000
2022-01-31	2022-01-27	4	McNulty Christopher	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,53		400.000		400.000
2022-01-31	2022-01-27	4	McKee Blaine H.	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,53		75.000		75.000
2022-01-31	2022-01-27	4	Mazaltov Avi	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,53		400.000		400.000
2022-01-31	2022-01-27	4	GILLIS STEVEN	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,53		100.000		100.000
2022-01-31	2022-01-27	4	Diaz-Mitoma Francisco	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,53		400.000		400.000
2022-01-31	2022-01-27	4	Cordeiro Joanne	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,53		75.000		75.000
2022-01-31	2022-01-27	4	Braga Damian	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,53		75.000		75.000
2022-01-31	2022-01-27	4	Beattie Nell	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,53		400.000		400.000
2022-01-31	2022-01-27	4	Baxter Jeff	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,53		800.000		800.000
2022-01-31	2022-01-27	4	Bain Linda	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,53		75.000		75.000
2022-01-31	2022-01-27	4	Anderson David Evander	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,53		400.000		400.000
2021-12-06	2021-12-03	4	Beattie Nell	VBIV	Common Shares, no par value per share	P - Purchase	D		2,4492	8.200	20		68.200
2021-12-03	2021-12-01	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	S - Sale	I		3,3100	-2.707.463	-8.962		52.334.993
2021-07-07	2021-07-01	4	Bain Linda	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,43		250.000		250.000
2021-06-30	2021-06-29	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	S - Sale	I		3,8000	-145.548	-553		0
2021-06-30	2021-06-29	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	S - Sale	I		3,8000	-500.709	-1.903		0
2021-06-11	2021-06-09	4	PERCEPTIVE ADVISORS LLC	VBIV	Warrant (right to buy)	X - Other	I	2,75		-465.936		0
2021-06-11	2021-06-09	4	PERCEPTIVE ADVISORS LLC	VBIV	Warrant (right to buy)	X - Other	I	2,75		-1.602.888		0
2021-06-11	2021-06-09	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	S - Sale	I		4,0000	-320.388	-1.282		145.548
2021-06-11	2021-06-09	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	S - Sale	I		4,0000	-1.102.179	-4.409		500.709
2021-06-11	2021-06-09	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	X - Other	I		2,7500	465.936	1.281		465.936
2021-06-11	2021-06-09	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	X - Other	I		2,7500	1.602.888	4.408		1.602.888
2021-02-01	2021-01-27	4	DeWilde Michel	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,15		75.000		75.000
2021-02-01	2021-01-27	4	Mazaltov Avi	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,14		500.000		500.000
2021-01-29	2021-01-27	4	McKee Blaine H.	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,15		75.000		75.000
2021-01-29	2021-01-27	4	Diaz-Mitoma Francisco	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,14		500.000		500.000
2021-01-29	2021-01-27	4	Braga Damian	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,15		75.000		75.000
2021-01-29	2021-01-27	4	Beattie Nell	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,15		500.000		500.000
2021-01-29	2021-01-27	4	Cordeiro Joanne	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,15		75.000		75.000
2021-01-29	2021-01-27	4	McNulty Christopher	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,15		500.000		500.000
2021-01-29	2021-01-27	4	Anderson David Evander	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,15		500.000		500.000
2021-01-29	2021-01-27	4	GILLIS STEVEN	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,15		100.000		100.000
2021-01-29	2021-01-27	4	Baxter Jeff	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,15		1.000.000		1.000.000
2020-07-02	2020-07-01	4	Baxter Jeff	VBIV	Option (Right to Buy Common Shares)	A - Award	D	2,94		425.200		425.200
2020-07-02	2020-07-01	4	Diaz-Mitoma Francisco	VBIV	Option (Right to Buy Common Shares)	A - Award	D	2,99		167.150		167.150
2020-07-02	2020-07-01	4	Mazaltov Avi	VBIV	Option (Right to Buy Common Shares)	A - Award	D	2,99		167.150		167.150
2020-07-02	2020-07-01	4	McNulty Christopher	VBIV	Option (Right to Buy Common Shares)	A - Award	D	2,94		170.100		170.100
2020-07-02	2020-07-01	4	Beattie Nell	VBIV	Option (Right to Buy Common Shares)	A - Award	D	2,94		170.100		170.100
2020-07-02	2020-07-01	4	Anderson David Evander	VBIV	Option (Right to Buy Common Shares)	A - Award	D	2,94		170.100		170.100
2020-04-28	2020-04-24	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	P - Purchase	I		1,1000	9.090.909	10.000		55.042.456
2020-03-24	2020-03-24	4	Braga Damian	VBIV	Option (Right to Buy Common Shares)	A - Award	D	0,81		250.000		250.000
2020-01-24	2020-01-22	4	McKee Blaine H.	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,46		250.000		250.000
2020-01-24	2020-01-22	4	GILLIS STEVEN	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,46		350.000		350.000
2020-01-24	2020-01-22	4	McNulty Christopher	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,46		350.000		350.000
2020-01-24	2020-01-22	4	Beattie Nell	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,46		350.000		350.000
2020-01-24	2020-01-22	4	Cordeiro Joanne	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,46		250.000		250.000
2020-01-24	2020-01-22	4	Diaz-Mitoma Francisco	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,66		350.000		350.000
2020-01-24	2020-01-22	4	Anderson David Evander	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,46		350.000		350.000
2020-01-24	2020-01-22	4	Mazaltov Avi	VBIV	Restricted Stock Units	A - Award	D			50.000		50.000
2020-01-24	2020-01-22	4	DeWilde Michel	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,46		250.000		250.000
2020-01-24	2020-01-22	4	Baxter Jeff	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,46		500.000		500.000
2019-10-07	2019-10-04	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share	P - Purchase	I		0,5000	40.000	20		117.500
2019-10-07	2019-09-30	4	Diaz-Mitoma Francisco By wife	VBIV	Common Shares, no par value per share	P - Purchase	I		0,5000	14.500	7		14.500
2019-10-01	2019-10-01	4	Beattie Nell	VBIV	Common Shares, no par value per share	P - Purchase	D		0,4822	10.000	5		60.000
2019-10-01	2019-10-01	4	McNulty Christopher	VBIV	Common Shares, no par value per share	P - Purchase	D		0,4730	12.000	6		37.000
2019-09-30	2019-09-30	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		0,5030	150.000	75		608.255
2019-09-24	2019-09-23	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	P - Purchase	I		0,5000	20.000.000	10.000		45.951.556
2019-07-01	2019-06-27	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share	P - Purchase	I		1,0700	8.000	9		77.500
2019-06-20	2019-06-20	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share	P - Purchase	I		0,8900	42.000	37		69.500
2019-06-20	2019-06-20	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share	P - Purchase	I		0,7800	10.000	8		27.500
2019-06-20	2019-06-18	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	P - Purchase	I		0,6500	1.000.000	650		25.951.556
2019-06-19	2019-06-19	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		0,7315	144.000	105		458.255
2019-06-19	2019-06-19	4	Beattie Nell	VBIV	Common Shares, no par value per share	P - Purchase	D		0,7357	8.000	6		50.000
2019-06-18	2019-06-14	4	GILLIS STEVEN	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-18.750		0
2019-06-18	2019-06-14	4	GILLIS STEVEN	VBIV	Common Shares, no par value per share	M - Exercise	D			18.750			84.416
2019-06-18	2019-06-14	4	Baxter Jeff	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-31.250		0
2019-06-18	2019-06-14	4	Baxter Jeff	VBIV	Common Shares, no par value per share	M - Exercise	D			31.250			314.255
2019-06-18	2019-06-14	4	Beattie Nell	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-6.250		0
2019-06-18	2019-06-14	4	Beattie Nell	VBIV	Common Shares, no par value per share	M - Exercise	D			6.250			42.000
2019-06-18	2019-06-14	4	DeWilde Michel	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-12.500		0
2019-06-18	2019-06-14	4	DeWilde Michel	VBIV	Common Shares, no par value per share	M - Exercise	D			12.500			50.000
2019-06-18	2019-06-14	4	Anderson David Evander	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-21.875		0
2019-06-18	2019-06-14	4	Anderson David Evander	VBIV	Common Shares, no par value per share	M - Exercise	D			21.875			148.209
2019-06-18	2019-06-17	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	P - Purchase	I		0,6180	1.000.000	618		24.951.556
2019-04-24	2019-04-18	4	Cordeiro Joanne	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,97		200.000		200.000
2019-02-04	2019-01-31	4	Beattie Nell	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,67		300.000		300.000
2019-02-04	2019-01-31	4	Beattie Nell	VBIV	Common Shares, no par value per share	A - Award	D			15.000			35.750
2019-02-04	2019-01-31	4	Anderson David Evander	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,67		300.000		300.000
2019-02-04	2019-01-31	4	Anderson David Evander	VBIV	Common Shares, no par value per share	A - Award	D			25.000			126.334
2019-02-04	2019-01-31	4	Mazaltov Avi	VBIV	Common Share	A - Award	D			90.000			196.000
2019-02-04	2019-01-31	4	Requadt Scott	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,67		200.000		200.000
2019-02-04	2019-01-31	4	McNulty Christopher	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,67		300.000		300.000
2019-02-04	2019-01-31	4	McNulty Christopher	VBIV	Common Shares, no par value per share	A - Award	D			25.000			25.000
2019-02-04	2019-01-31	4	DeWilde Michel	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,67		200.000		200.000
2019-02-04	2019-01-31	4	Baxter Jeff	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,67		450.000		450.000
2019-02-04	2019-01-31	4	Baxter Jeff	VBIV	Common Shares, no par value per share	A - Award	D			50.000			283.005
2019-02-04	2019-01-31	4	Diaz-Mitoma Francisco	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,64		300.000		300.000
2019-02-04	2019-01-31	4	GILLIS STEVEN	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,67		300.000		300.000
2019-02-04	2019-01-31	4	McKee Blaine H.	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,67		300.000		300.000
2019-02-04	2019-01-31	4	Kariv Tomer	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,64		200.000		200.000
2018-12-18	2018-12-17	4	Kariv Tomer By Pontifax Late Stage Fund L.P.	VBIV	Common Stock	P - Purchase	I		1,4000	185.714	260		185.714
2018-12-18	2018-12-17	4	Kariv Tomer By Pontifax (China) IV Limited Partnership	VBIV	Common Stock	P - Purchase	I		1,4000	331.429	464		943.451
2018-12-18	2018-12-17	4	Kariv Tomer By Pontifax (Cayman) IV Limited Partnership	VBIV	Common Stock	P - Purchase	I		1,4000	298.431	418		849.520
2018-12-18	2018-12-17	4	Kariv Tomer By Pontifax (Israel) IV Limited Partnership	VBIV	Common Stock	P - Purchase	I		1,4000	612.997	858		1.744.969
2018-12-17	2018-12-13	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	P - Purchase	I		1,4000	14.285.714	20.000		23.631.439
2018-09-21	2018-09-19	4	McNulty Christopher	VBIV	Option (Right to Buy Common Shares)	A - Award	D	1,83		250.000		250.000
2018-08-07	2018-08-06	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		1,9268	8.100	16		233.005
2018-08-06	2018-08-03	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share	P - Purchase	I		2,1000	6.000	13		17.500
2018-08-06	2018-08-02	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share	P - Purchase	I		2,2000	3.000	7		11.500
2018-08-06	2018-08-03	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		2,0082	13.500	27		224.905
2018-08-03	2018-08-03	4	Beattie Nell	VBIV	Common Shares, no par value per share	P - Purchase	D		2,0057	2.000	4		20.750
2018-08-01	2018-07-31	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		2,2760	16.800	38		211.405
2018-07-03	2018-06-14	4/A	Anderson David Evander	VBIV	Common Shares, no par value per share	F - Taxes	D		3,7600	-9.281	-35		101.334
2018-06-29	2018-01-23	4/A	Mazaltov Avi	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4,19		0		0
2018-06-29	2018-01-23	4/A	Mazaltov Avi	VBIV	Common Share	A - Award	D			100.000			106.000
2018-06-25	2018-06-14	4	GILLIS STEVEN	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-18.750		18.750
2018-06-25	2018-06-14	4	GILLIS STEVEN	VBIV	Common Shares, no par value per share	M - Exercise	D			18.750			65.666
2018-06-20	2018-06-14	4	DeWilde Michel	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-12.500		12.500
2018-06-20	2018-06-14	4	DeWilde Michel	VBIV	Common Shares, no par value per share	M - Exercise	D			12.500			37.500
2018-06-18	2018-06-14	4	Requadt Scott	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-12.500		12.500
2018-06-18	2018-06-14	4	Requadt Scott	VBIV	Common Shares, no par value per share	M - Exercise	D			12.500			37.500
2018-06-18	2018-06-14	4	Rubin Steven D	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-18.750		18.750
2018-06-18	2018-06-14	4	Rubin Steven D	VBIV	Common Shares, no par value per share	M - Exercise	D			18.750			56.250
2018-06-18	2018-06-14	4	Baxter Jeff	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-31.250		31.250
2018-06-18	2018-06-14	4	Baxter Jeff	VBIV	Common Shares, no par value per share	M - Exercise	D			31.250			194.605
2018-06-18	2018-06-14	4	Beattie Nell	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-6.250		6.250
2018-06-18	2018-06-14	4	Beattie Nell	VBIV	Common Shares, no par value per share	M - Exercise	D			6.250			18.750
2018-06-18	2018-06-14	4	Anderson David Evander	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-21.875		21.875
2018-06-18	2018-06-14	4	Anderson David Evander	VBIV	Common Shares, no par value per share	F - Taxes	D		3,7600	-9.306	-35		101.309
2018-06-18	2018-06-14	4	Anderson David Evander	VBIV	Common Shares, no par value per share	M - Exercise	D			21.875			110.615
2018-06-18	2018-06-14	4	Logal Adam	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-12.500		12.500
2018-06-18	2018-06-14	4	Logal Adam	VBIV	Common Shares, no par value per share	M - Exercise	D			12.500			37.500
2018-05-25	2018-05-24	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		2,9900	11.000	33		163.355
2018-05-14	2018-05-11	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		2,9100	7.100	21		152.355
2018-05-14	2018-05-11	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value	P - Purchase	D		3,1300	4.500	14		268.839
2018-05-14	2018-05-11	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value	P - Purchase	I		2,9800	5.500	16		8.500
2018-02-06	2018-01-23	4	Kartsaklis Athena	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4,26		75.000		75.000
2018-01-30		3	Mazaltov Avi	VBIV	Common Shares, no par value per share		D						12.000
2018-01-30		3	Mazaltov Avi	VBIV	Common Shares, no par value per share		D						12.000
2018-01-30	2018-01-23	4	Mazaltov Avi	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4,19		100.000		100.000
2018-01-29		3	Kariv Tomer By Pontifax (China) IV Limited Partnership	VBIV	Common Stock		I						2.907.105
2018-01-29		3	Kariv Tomer By Pontifax (Israel) IV Limited Partnership	VBIV	Common Stock		I						3.427.055
2018-01-29		3	Kariv Tomer By Pontifax (Cayman) IV Limited Partnership	VBIV	Common Stock		I						2.846.172
2018-01-29		3	Kariv Tomer By Pontifax (China) IV Limited Partnership	VBIV	Common Stock		I						2.907.105
2018-01-29		3	Kariv Tomer By Pontifax (Israel) IV Limited Partnership	VBIV	Common Stock		I						3.427.055
2018-01-29		3	Kariv Tomer By Pontifax (Cayman) IV Limited Partnership	VBIV	Common Stock		I						2.846.172
2018-01-29	2018-01-23	4	Kariv Tomer	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4,19		75.000		75.000
2018-01-26	2018-01-23	4	DeWilde Michel	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4,19		75.000		75.000
2018-01-25	2018-01-23	4	GILLIS STEVEN	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4,19		100.000		100.000
2018-01-25	2018-01-23	4	Logal Adam	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4,19		75.000		75.000
2018-01-25	2018-01-23	4	Rubin Steven D	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4,19		75.000		75.000
2018-01-25	2018-01-23	4	Diaz-Mitoma Francisco	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4,26		100.000		100.000
2018-01-25	2018-01-23	4	Beattie Nell	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4,19		100.000		100.000
2018-01-25	2018-01-23	4	Anderson David Evander	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4,19		100.000		100.000
2018-01-25	2018-01-23	4	Buckley T. Adam	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4,19		75.000		75.000
2018-01-25	2018-01-23	4	Requadt Scott	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4,19		75.000		75.000
2018-01-25	2018-01-23	4	Baxter Jeff	VBIV	Option (Right to Buy Common Shares)	A - Award	D	4,19		150.000		150.000
2017-12-13	2017-12-12	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		3,8800	4.609	18		145.255
2017-12-13	2017-12-12	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		3,8900	5.391	21		140.646
2017-11-29	2017-11-28	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		4,7500	15.000	71		135.255
2017-11-09		3	Opko Health, Inc.	VBIV	Common Stock		D						12.046.028
2017-11-09		3	Opko Health, Inc.	VBIV	Common Stock		D						12.046.028
2017-11-01	2017-10-30	4	Opko Health, Inc.	VBIV	Common Stock	P - Purchase	D		3,0500	655.738	2.000		6.678.752
2017-10-31		3	Nussbaum Ran By Pontifax (Israel) IV Limited Partnership	VBIV	Common Shares, no par value per share		I						3.427.055
2017-10-31		3	Nussbaum Ran By Pontifax (Cayman) IV Limited Partnership	VBIV	Common Shares, no par value per share		I						2.846.172
2017-10-31		3	Nussbaum Ran By Pontifax (China) IV Limited Partnership	VBIV	Common Shares, no par value per share		I						2.907.105
2017-10-31		3	Nussbaum Ran By Pontifax (Israel) IV Limited Partnership	VBIV	Common Shares, no par value per share		I						3.427.055
2017-10-31		3	Nussbaum Ran By Pontifax (Cayman) IV Limited Partnership	VBIV	Common Shares, no par value per share		I						2.846.172
2017-10-31		3	Nussbaum Ran By Pontifax (China) IV Limited Partnership	VBIV	Common Shares, no par value per share		I						2.907.105
2017-10-31	2017-10-30	4	CHAWLA SAM	VBIV	Common Shares, no par value per share	P - Purchase	I		3,0500	3.100.000	9.455		9.345.725
2017-10-31	2017-10-30	4	GILLIS STEVEN	VBIV	Common Shares, no par value per share	P - Purchase	I		3,0500	300.000	915		3.026.057
2017-10-30	2017-10-26	4	PERCEPTIVE ADVISORS LLC	VBIV	Common Stock	P - Purchase	I		3,0500	3.100.000	9.455		9.345.725
2017-08-22	2017-08-21	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share	P - Purchase	I		3,1700	3.000	10		3.000
2017-08-22	2017-08-21	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		3,2200	10.000	32		120.255
2017-08-14	2017-08-10	4	Baxter Jeff	VBIV	Common Shares, no par value per share	P - Purchase	D		3,2800	10.000	33		110.255
2017-06-23	2017-06-22	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share	A - Award	D			12.500			264.339
2017-06-16	2017-06-14	4	DeWilde Michel	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-12.500		25.000
2017-06-16	2017-06-14	4	DeWilde Michel	VBIV	Common Shares, no par value per share	M - Exercise	D			12.500			25.000
2017-06-16	2017-06-14	4	Buckley T. Adam	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-4.687		9.374
2017-06-16	2017-06-14	4	Buckley T. Adam	VBIV	Common Shares, no par value per share	M - Exercise	D			4.687			44.063
2017-06-16	2017-06-14	4	Rubin Steven D	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-18.750		37.500
2017-06-16	2017-06-14	4	Rubin Steven D	VBIV	Common Shares, no par value per share	M - Exercise	D			18.750			37.500
2017-06-16	2017-06-14	4	GILLIS STEVEN	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-18.750		37.500
2017-06-16	2017-06-14	4	GILLIS STEVEN	VBIV	Common Shares, no par value per share	M - Exercise	D			18.750			46.916
2017-06-16	2017-06-14	4	CHAWLA SAM	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-12.500		25.000
2017-06-16	2017-06-14	4	CHAWLA SAM	VBIV	Common Shares, no par value per share	M - Exercise	D			12.500			25.000
2017-06-16	2017-06-14	4	Requadt Scott	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-12.500		25.000
2017-06-16	2017-06-14	4	Requadt Scott	VBIV	Common Shares, no par value per share	M - Exercise	D			12.500			25.000
2017-06-16	2017-06-14	4	Anderson David Evander	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-21.875		43.750
2017-06-16	2017-06-14	4	Anderson David Evander	VBIV	Common Shares, no par value per share	M - Exercise	D			21.875			88.740
2017-06-16	2017-06-14	4	Baxter Jeff	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-31.250		62.500
2017-06-16	2017-06-14	4	Baxter Jeff	VBIV	Common Shares, no par value per share	M - Exercise	D			31.250			100.255
2017-06-16	2017-06-14	4	Beattie Nell	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-6.250		12.500
2017-06-16	2017-06-14	4	Beattie Nell	VBIV	Common Shares, no par value per share	M - Exercise	D			6.250			12.500
2017-06-16	2017-06-14	4	Logal Adam	VBIV	Restricted Stock Units (RSUs)	M - Exercise	D			-12.500		25.000
2017-06-16	2017-06-14	4	Logal Adam	VBIV	Common Shares, no par value per share	M - Exercise	D			12.500			25.000
2017-04-27		3	Baxter Jeff	VBIV	Common Shares, no par value per share		D						138.010
2017-04-27		3	Baxter Jeff	VBIV	Common Shares, no par value per share		D						138.010
2017-04-27		3	DeWilde Michel	VBIV	Common Shares, no par value per share		D						25.000
2017-04-27		3	DeWilde Michel	VBIV	Common Shares, no par value per share		D						25.000
2017-04-27	2017-04-18	4	Baxter Jeff	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,79		20.000		20.000
2017-04-27	2017-04-17	4	DeWilde Michel	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,79		12.500		12.500
2017-04-04		3	Anderson David Evander	VBIV	Common Shares, no par value per share		D						133.730
2017-04-04		3	Anderson David Evander	VBIV	Common Shares, no par value per share		D						133.730
2017-04-04		3	Beattie Nell	VBIV	Common Shares, no par value per share		D						12.500
2017-04-04		3	Beattie Nell	VBIV	Common Shares, no par value per share		D						12.500
2017-04-04		3	Requadt Scott	VBIV	Common Shares, no par value per share		D						2.716.042
2017-04-04		3	Requadt Scott	VBIV	Common Shares, no par value per share		I						5.394.584
2017-04-04		3	Requadt Scott	VBIV	Common Shares, no par value per share		D						2.716.042
2017-04-04		3	Requadt Scott	VBIV	Common Shares, no par value per share		I						5.394.584
2017-04-04	2017-04-03	4	Beattie Nell	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,79		20.000		20.000
2017-04-04	2017-03-31	4	Requadt Scott	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,79		12.500		12.500
2017-04-04	2017-03-31	4	Anderson David Evander	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,79		20.000		20.000
2017-03-31		3	Logal Adam	VBIV	Common Shares, no par value per share		D						25.000
2017-03-31		3	Logal Adam	VBIV	Common Shares, no par value per share		D						25.000
2017-03-31		3	CHAWLA SAM	VBIV	Common Shares, no par value per share		D						6.590.843
2017-03-31		3	CHAWLA SAM	VBIV	Common Shares, no par value per share		I						13.144.186
2017-03-31		3	CHAWLA SAM	VBIV	Common Shares, no par value per share		I						13.144.186
2017-03-31		3	CHAWLA SAM	VBIV	Common Shares, no par value per share		D						6.590.843
2017-03-31		3	Nascimento Egidio	VBIV	Common Shares, no par value per share		D						5.936
2017-03-31		3	Nascimento Egidio	VBIV	Common Shares, no par value per share		D						5.936
2017-03-31		3	Buckley T. Adam	VBIV	Common Shares, no par value per share		D						78.752
2017-03-31		3	Buckley T. Adam	VBIV	Common Shares, no par value per share		D						78.752
2017-03-31		3	Rubin Steven D	VBIV	Common Shares, no par value per share		D						37.500
2017-03-31		3	Rubin Steven D	VBIV	Common Shares, no par value per share		D						37.500
2017-03-31		3	GILLIS STEVEN	VBIV	Common Shares, no par value per share		I						5.473.903
2017-03-31		3	GILLIS STEVEN	VBIV	Common Shares, no par value per share		D						2.769.635
2017-03-31		3	GILLIS STEVEN	VBIV	Common Shares, no par value per share		I						5.473.903
2017-03-31		3	GILLIS STEVEN	VBIV	Common Shares, no par value per share		D						2.769.635
2017-03-31		3	Eckenswiller Catherine	VBIV	Common Shares, no par value per share		D						0
2017-03-31		3	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share		I						278.147
2017-03-31		3	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share		I						278.147
2017-03-31		3	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share		D						498.082
2017-03-31		3	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share		D						498.082
2017-03-31	2017-03-29	4	Diaz-Mitoma Francisco	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,45		20.000		20.000
2017-03-31	2017-03-29	4	Diaz-Mitoma Francisco	VBIV	Common Shares, no par value per share	A - Award	D			12.500			251.839
2017-03-31	2017-03-30	4	Rubin Steven D	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,79		12.500		12.500
2017-03-31	2017-03-29	4	GILLIS STEVEN	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,79		15.000		15.000
2017-03-31	2017-01-17	4	GILLIS STEVEN	VBIV	Option (Right to Buy Common Shares)	M - Exercise	D	2,50	2,5000	-6.377	-16	0
2017-03-31	2017-01-17	4	GILLIS STEVEN	VBIV	Common Shares, no par value per share	M - Exercise	D		2,5000	6.377	16		28.166
2017-03-31	2017-03-31	4	Eckenswiller Catherine	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,45		3.000		3.000
2017-03-31	2017-03-30	4	Nascimento Egidio	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,45		20.000		20.000
2017-03-31	2017-03-30	4	Buckley T. Adam	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,79		20.000		20.000
2017-03-31	2017-03-30	4	Logal Adam	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,79		12.500		12.500
2017-03-31	2017-03-30	4	CHAWLA SAM	VBIV	Option (Right to Buy Common Shares)	A - Award	D	3,79		12.500		12.500

Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer

Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer

Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)

Konvertering af derivat

Salg eller overførsel af værdipapirer tilbage til virksomheden

Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet

Gave af værdipapirer af eller til insideren

Aktieswaps og lignende sikringstransaktioner

Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)

En transaktion rapporteret frivilligt på formular 4

Andet (ledsaget af en fodnote, der beskriver transaktionen)

SVACF / SciVac Therapeutics Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5